FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Fresenius Kabi Tranexamic Acid Injection Recall

Tranexamic Acid Injection USP, 1000mg/10mL, 10mL vial, Rx only

Fresenius Kabi USA, LLC · Lake Zurich, IL

Risk level
Class II
Reported by FDA
Jan 29, 2014
Recall ID
D-1034-2014
Check your lot numberHow we source this data

Summary

Fresenius Kabi recalled Tranexamic Acid Injection starting Oct 31, 2013. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-1034-2014 on Jan 29, 2014. Reason: Presence of Particulate Matter: Particulate matter consistent with delamination of the glass vial container. Status: Terminated.

Why it was recalled

Presence of Particulate Matter: Particulate matter consistent with delamination of the glass vial container.

Product description

Tranexamic Acid Injection USP, 1000mg/10mL, 10mL vial, Rx only. Mfd by: Fresenius Kabi USA, LLC Packaged under two labels: 1) Mfd for: APP Pharmaceuticals, LLC; Schaumburg, IL 60173, NDC 63323-563-10, and 2) Mfd in USA; for Nexus Pharmaceuticals Inc; Vernon Hills, IL 60061. NDC 14789-500-10.

Lot numbers, UPCs & expiration codes

National Drug Code (NDC): 63323-563-10; Lot Numbers and (Expiration Dates): 011713 (01/2015); 012213 (01/2015), 032913 (03/2015), 041613 (04/2015); 042513 (04/2015), 042613 (04/2015), 052213 (05/2015), 092612 (09/2014), 111512 (11/2014) NDC: 14789-500-10; 122911 (12/2013), 123011 (12/2013)

Where it was sold

US: Nationwide

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-1034-2014
Classification
Class II
Status
Terminated
Recall initiated
Oct 31, 2013
FDA report date
Jan 29, 2014
Quantity
121,456 vials
Recall type
Voluntary: Firm initiated
Recalling firm
Fresenius Kabi USA, LLC

Original FDA data

Every field from FDA enforcement report D-1034-2014, exactly as published.

Show all FDA fields
City
Lake Zurich
State
IL
Status
Terminated
Country
United States
Event ID
66678
Address
3 Corporate Dr
Code information
National Drug Code (NDC): 63323-563-10; Lot Numbers and (Expiration Dates): 011713 (01/2015); 012213 (01/2015), 032913 (03/2015), 041613 (04/2015); 042513 (04/2015), 042613 (04/2015), 052213 (05/2015), 092612 (09/2014), 111512 (11/2014) NDC: 14789-500-10; 122911 (12/2013), 123011 (12/2013)
Postal code
60047-8930
Report date
Jan 29, 2014
Product type
Drugs
Recall number
D-1034-2014
Classification
Class II
Recalling firm
Fresenius Kabi USA, LLC
Product quantity
121,456 vials
Termination date
Jan 7, 2016
Reason for recall
Presence of Particulate Matter: Particulate matter consistent with delamination of the glass vial container.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Tranexamic Acid Injection USP, 1000mg/10mL, 10mL vial, Rx only. Mfd by: Fresenius Kabi USA, LLC Packaged under two labels: 1) Mfd for: APP Pharmaceuticals, LLC; Schaumburg, IL 60173, NDC 63323-563-10, and 2) Mfd in USA; for Nexus Pharmaceuticals Inc; Vernon Hills, IL 60061. NDC 14789-500-10.
Distribution pattern
US: Nationwide
Recall initiation date
Oct 31, 2013
Initial firm notification
Letter
Center classification date
Jan 23, 2014

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-1034-2014, published Jan 29, 2014. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls